{{Rsnum
|rsid=1143770
|Gene=MIRLET7A2
|Chromosome=11
|position=122146890
|Orientation=plus
|GMAF=0.4867
|Gene_s=MIRLET7A2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 16.9 | 56.9 | 26.2
| HCB | 21.4 | 38.1 | 40.5
| JPT | 31.0 | 52.4 | 16.7
| YRI | 23.8 | 47.6 | 28.6
| ASW | 0.0 | 0.0 | 0.0
| CHB | 21.4 | 38.1 | 40.5
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=23860321
|Title=A potentially functional polymorphism in the regulatory region of let-7a-2 is associated with an increased risk for diabetic nephropathy
}}
{{PMID Auto
|PMID=24760009
|Title=A New Polymorphism Biomarker rs629367 Associated with Increased Risk and Poor Survival of Gastric Cancer in Chinese by Up-Regulated miRNA-let-7a Expression
|OA=1
}}